Ethics approval and consent to participate
The study was approved by the regional ethics review board in Stockholm, Sweden (Dnr: 2017/124–31/2, 2018/2224–32) and The London Brent Research Ethics Committee (REC), UK (18/LO/1190). Written consent is/will be signed by all participating patients.